Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21 ; volume:22 ; number:1 ; day:8 ; month:8 ; year:2022 ; pages:1-7 ; date:12.2022
BMC public health ; 22, Heft 1 (8.8.2022), 1-7, 12.2022
- Urheber
-
Syrkina, Olga
Inamdar, Ajinkya
Wague, Sophie
Monfredo, Céline
Nissilä, Markku
Chabanon, Anne-Laure
Serradell, Laurence
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-022-13898-z
- URN
-
urn:nbn:de:101:1-2022102419593066739653
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Syrkina, Olga
- Inamdar, Ajinkya
- Wague, Sophie
- Monfredo, Céline
- Nissilä, Markku
- Chabanon, Anne-Laure
- Serradell, Laurence
- SpringerLink (Online service)
Ähnliche Objekte (12)
Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
Downstream processing of influenza whole-virions for vaccine production
Enhanced Safety Surveillance of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season
Expression and incorporation of foreign glycoproteins in influenza virions via the influenza RNA polymerase I system
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Safety Profile of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season
Nasal spray live attenuated influenza vaccine: the first experience in Italy in children and adolescents during the 2020–21 season
Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network
Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)
Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
Downstream processing of influenza whole-virions for vaccine production
Enhanced Safety Surveillance of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season
Expression and incorporation of foreign glycoproteins in influenza virions via the influenza RNA polymerase I system
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Safety Profile of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season
Nasal spray live attenuated influenza vaccine: the first experience in Italy in children and adolescents during the 2020–21 season
Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network
Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)
Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
Downstream processing of influenza whole-virions for vaccine production
Enhanced Safety Surveillance of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season
Expression and incorporation of foreign glycoproteins in influenza virions via the influenza RNA polymerase I system
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
Safety Profile of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season
Nasal spray live attenuated influenza vaccine: the first experience in Italy in children and adolescents during the 2020–21 season
Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network